Adient PLC
NYSE:ADNT
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Adient PLC
NYSE:ADNT
|
IE |
|
Suruga Bank Ltd
TSE:8358
|
JP |
|
Seven West Media Ltd
OTC:WANHY
|
AU |
|
Connect Biopharma Holdings Ltd
NASDAQ:CNTB
|
CN |
|
A
|
Alma Gold Inc
OTC:ALGLF
|
CA |
|
Grange Resources Ltd
ASX:GRR
|
AU |
|
Champion Iron Ltd
TSX:CIA
|
AU |
|
Klepierre SA
OTC:KLPEF
|
FR |
|
T
|
Tupperware Brands Corp
SWB:TUP
|
US |
|
R
|
REA Group Ltd
OTC:RPGRY
|
AU |
|
K
|
Kansas City Southern
LSE:0JQ4
|
US |
|
Swedish Orphan Biovitrum AB (publ)
STO:SOBI
|
SE |
|
Bangkok Dusit Medical Services PCL
OTC:BDUUY
|
TH |
|
Y
|
Yellow Cake PLC
LSE:YCA
|
JE |
Wall St Price Targets
ADNT Price Targets Summary
Adient PLC
According to Wall Street analysts, the average 1-year price target for
ADNT is 30.98 USD with a low forecast of 22.22 USD and a high forecast of 54.72 USD.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is ADNT's stock price target?
Price Target
30.98
USD
According to Wall Street analysts, the average 1-year price target for
ADNT is 30.98 USD with a low forecast of 22.22 USD and a high forecast of 54.72 USD.
What is the Revenue forecast for Adient PLC?
Projected CAGR
3%
Over the last 13 years, the compound annual growth rate for Revenue has been -2%. The projected CAGR for the next 5 years is 3%.
What is the Operating Income forecast for Adient PLC?
Projected CAGR
14%
Over the last 13 years, the compound annual growth rate for Operating Income has been 1%. The projected CAGR for the next 5 years is 14%.